Quantcast
Last updated on April 23, 2014 at 13:36 EDT

Latest Tremor Stories

2013-03-06 08:27:22

HORSHOLM, Denmark, March 6, 2013 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO) ('Veloxis') today published the annual report of Veloxis Pharmaceuticals A/S for the financial year 2012. The annual report has been prepared in accordance with International Financial Reporting Standards as adopted by the EU and additional Danish disclosure requirements for annual reports of listed companies. This company announcement should be read in conjunction with Veloxis' annual report 2012...

2013-02-19 08:34:24

TIRAT CARMEL, Israel, February 19, 2013 /PRNewswire/ -- InSightec Ltd announced that it has received FDA approval to begin its pivotal Phase III clinical trial for treatment of essential tremor using ExAblate(R) Neuro. This trial is intended to provide the safety and effectiveness data about the use of ExAblate(R) Neuro in order to support FDA pre-marketing approval. ExAblate Neuro uses MR guided focused ultrasound therapy to provide an incision-less treatment, through...

2012-12-06 08:28:06

HORSHOLM, Denmark, Dec. 6, 2012 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO) today announced results of a preliminary analysis from the first 16 patients in its Switching STudy of Kidney TRansplant PAtients with Tremor to LCP-TacrO (STRATO) clinical trial. Results from the first 16 patients demonstrated a trend toward a reduction in tremor following the switch from twice-daily tacrolimus to once-daily LCP-Tacro. "Tremor is a common side effect of tacrolimus administration and it...

2012-08-20 02:30:40

TIRAT CARMEL, Israel, August 20, 2012 /PRNewswire/ -- InSightec [http://www.insightec.com ] Ltd, the global leader in MR guided Focused Ultrasound (MRgFUS), announced that it has received approval from the US Food and Drug Administration (FDA) to begin a Phase I clinical trial evaluating the use of its ExAblate(R) Neuro [http://www.insightec.com/ExAblate-Neuro.html ] system for the treatment of patients with tremor dominant Parkinson's Disease. Thirty patients who suffer...

2012-08-03 01:15:40

People suffering from the 'essential tremor' disorder can now be more easily diagnosed Researchers at the University of Montreal and its affiliated CHU Sainte-Justine and CHUM hospitals have linked some cases of Essential Tremor (ET) to a specific genetic problem. ET is the most common movement disorder, becoming increasingly frequent with increasing age, which is characterized by an involuntary shaking movement (tremor) that occurs with motion, particularly when doing precise fine...

2012-07-31 10:26:19

HOPKINTON, Mass., July 31, 2012 /PRNewswire/ -- Alseres Pharmaceuticals, Inc. (OTC: ALSE) today announced that it has entered into an agreement with Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB, "Navidea") to license, [(123)I]-E-IACFT Injection (CFT), also called Altropane®, an Iodine-123 radiolabeled imaging agent, being developed as an aid in the diagnosis of Parkinson's disease and movement disorders. "We are pleased to have completed this agreement with Navidea. With its focus,...

2012-07-05 06:33:55

(Ivanhoe Newswire) — Botox — it´s not just for wrinkles! It´s been known to reduce fine lines, help chronic headaches, and reduce sweating. Now, it can help those suffering from multiple sclerosis (MS). According to new research, the Botulinum toxin may help prevent shaking or tremor in the arms and hands of people with MS. "Treatments in use for tremor in MS are not sufficiently effective and new alternatives are needed," study author Anneke van der Walt, MD,...

2012-07-03 10:52:36

Botulinum toxin may help prevent shaking or tremor in the arms and hands of people with multiple sclerosis (MS), according to new research published in the July 3, 2012, print issue of Neurology®, the medical journal of the American Academy of Neurology. "Treatments in use for tremor in MS are not sufficiently effective and new alternatives are needed," said study author Anneke van der Walt, MD, consultant neurologist at The Royal Melbourne Hospital and research fellow with the...

2012-05-01 02:27:55

BROOKLYN, N.Y., May 1, 2012 /PRNewswire/ -- Eyes on the Go, Inc. (AXCG.PK) has entered into a partnership agreement with Tremor Video, the largest independent online video ad solutions provider to Fortune 1000 brand advertisers and top tier publishers including clients like Coca-Cola, Ford, IBM, Marriott and UPS. Eyes will integrate Tremor Video's ad technology into its GANDER.tv web site, which delivers streaming video and audio from entertainment venues. This partnership will enable...

2012-04-20 06:22:01

ATLANTA, April 20, 2012 /PRNewswire/ -- To help people learn more about the full range of symptoms associated with Parkinson's disease, global biopharmaceutical company UCB, Inc., is launching a new online community -- Parkinson's More than Motion(TM) -- that provides a platform for people living with Parkinson's disease and their caregivers to interact and learn from others with the condition. Part of this launch is the debut of a new reality-style video series depicting real families...